Orchid Pharma Limited
Press Release
Orchid Pharma Limited has entered into a licensing and supply agreement with Laboratorio Libra S.A. for Exblifep (Cefepime/Enmetazobactam) across nine Latin American markets, with a potential commercial opportunity of approximately USD 80 million over the first 10 years.